Rapid-Infusion Rituximab in Lymphoma Treatment: 2-Year Experience in a Single Institution

Journal of Oncology Practice, 05/24/2012

A rapid infusion rituximab over 90minutes is well tolerated and safe when administered as the second and subsequent infusions in the course of therapy.

Print Article Summary